| Serial Number | 79388905 |
| Word Mark | AVAXZIPEN |
| Filing Date | Friday, March 31, 2023 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Wednesday, September 25, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceutical, biopharmaceutical and veterinary preparations and substances for the treatment of and protection against disease; pharmaceutical, biopharmaceutical and veterinary preparations and substances for the treatment of or protection against viral, metabolic, musculoskeletal, cardiovascular, genitourinary, central nervous system, endocrinological, immunological, obstetrical, gynaecological, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders; prophylactic pharmaceutical and veterinary preparations and substances, namely for the treatment of infectious and autoimmune diseases; vaccines; prophylactic vaccines; therapeutic vaccines; vaccine preparations; biological preparations for medical use, namely, mixed biological preparations for the prevention and treatment of infectious and autoimmune diseases; biological, chemical and biochemical reagents for medical use; contraceptive preparations and substances, namely, oral, chemical and parenteral based contraceptives |
| Goods and Services | Surgical apparatus and instruments; medical, dental and veterinary apparatus and instruments, namely, injection and infusion devices for administering pharmaceutical, biopharmaceutical and veterinary preparations; drug delivery devices sold empty, namely, injection devices; actuator devices being injection devices sold empty for injecting pharmaceutical, biopharmaceutical and veterinary preparations parenterally; actuator devices being injection devices sold empty for injecting pharmaceutical, biopharmaceutical and veterinary preparations into subcutaneous tissue; actuator devices being injection devices sold empty for injecting pharmaceutical, biopharmaceutical and veterinary preparations into intradermal tissue; actuator devices being injection devices sold empty for injecting pharmaceutical, biopharmaceutical and veterinary preparations into intramuscular tissue; drug delivery devices, namely, drug cassettes sold empty; drug delivery devices, namely medical injectors, needle-free injectors, injectors with needles, all sold empty; drug delivery devices, sold empty, namely, medical injectors, needle-free injectors and parts and fittings therefore; actuator devices for use in drug delivery devices, namely handheld spring-powered and handheld gas-powered devices for injecting pharmaceutical, biopharmaceutical and veterinary preparations parenterally; actuator devices for use in drug delivery devices, namely handheld spring-powered and handheld gas-powered devices sold empty for injecting pharmaceutical, biopharmaceutical and veterinary preparations into subcutaneous tissue; actuator devices for use in drug delivery devices, namely handheld spring-powered and handheld gas-powered devices for injecting pharmaceutical, biopharmaceutical and veterinary preparations into intradermal tissue; actuator devices for use in drug delivery devices, namely handheld spring-powered and handheld gas-powered devices sold empty for injecting pharmaceutical, biopharmaceutical and veterinary preparations into intramuscular tissue; pre-loaded drug cassettes for use in drug delivery devices to contain pharmaceutical and biopharmaceutical preparations and substances for therapeutic, prophylactic and diagnostic use; Structural parts and fittings for all the aforesaid goods |
| Goods and Services | Medical and veterinary research and product development services; medical and veterinary device development services; pharmaceutical and biopharmaceutical development services; Product development of pharmaceutical and biopharmaceutical delivery systems; Pharmaceutical and biopharmaceutical product development, namely research and formulation of pharmaceuticals and biopharmaceuticals; research into vaccines; Product testing services for medical and veterinary devices and products; provision of information relating to product development and testing; Consulting services in the field of product development and testing |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, February 12, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, February 12, 2024 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, February 12, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | AVAXZIPEN LIMITED |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | GB |
| Event Date | Event Description |
| Friday, February 9, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Monday, February 12, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, February 16, 2024 | APPLICATION FILING RECEIPT MAILED |
| Monday, February 12, 2024 | ASSIGNED TO EXAMINER |
| Monday, March 25, 2024 | REFUSAL PROCESSED BY MPU |
| Tuesday, September 24, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, September 24, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, September 25, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, April 16, 2024 | REFUSAL PROCESSED BY IB |
| Friday, March 1, 2024 | NON-FINAL ACTION WRITTEN |
| Saturday, March 2, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, March 25, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |